BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Ultrasound Gel Warmers Market: Increase in the number of ultrasound procedures to drive the market

  Gel warmers are widely used to maintain and balance the body temperature of a patient and during ultrasound procedure.

  February 24, 2022

   · 

  6 min read
• Global Ophthalmic Ultrasound Devices Market Demand and Global Industry Analysis

  Ultrasound technologies have been used prolifically in ophthalmology for treating wide range of pathologies, particularly glaucoma, retinal disorders, and tumors.

  February 24, 2022

   · 

  6 min read
• Heel Pressure Injury Relieving Devices Market: Growing Cases of Pressure Ulcer to Drive the Market

  The global heel pressure injury relieving devices market may have risen at a healthy pace in the past few years owing to the rising population suffering from terminal illness.

  February 24, 2022

   · 

  5 min read
• Medical Flexible Packaging Market to Generate an Absolute Opportunity of USD 15.2 Billion by 2032

  Fact.MR – A Market research and competitive intelligence provider: The global medical flexible packaging market value is estimated at USD 25.7 Billion in 2022 and is forecast to surpass a valuation of USD 40.9 Billion by 2032, growing market size at a CAGR of 4.7% from 2022 to 2032.

  February 24, 2022

   · 

  6 min read
• Veterinary Pain Management Market Outlook 2026

  Rapid advances in the global veterinary pain management market stem from the momentum gained from rising awareness about pain management in companion animals, especially cats and dogs.

  February 24, 2022

   · 

  5 min read
• Drug Development

  Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer

  On February 23 2022, Simcere Pharmaceutical Group announced that the phase III clinical registration study of Trilaciclib in patients with extensive-stage small cell lung cancer has met its primary endpoint.

  February 24, 2022

   · 

  3 min read
• Business

  Saniona publishes its year-end report for 2021

  Saniona received SEK 7.3 million (US$0.8 million) from Novartis related to Novartis’s January 2021 acquisition of Cadent Therapeutics, in which Saniona held a 3% ownership stake.

  February 24, 2022

   · 

  4 min read
• Business

  Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress

  Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company fearlessly leading the way to create a world with better brain health, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2021.

  February 24, 2022

   · 

  25 min read
• Business

  ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team

  ANI Pharmaceuticals appoints Mary Pao, M.D., Ph.D., as Chief Medical Officer, Rare Disease, and Elizabeth Powell, J.D., as Chief Compliance Officer and Head of Legal, Rare Disease.

  February 24, 2022

   · 

  6 min read
• Business

  ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results

  ProQR Therapeutics N.V. reported its financial and operating results for the fourth quarter and full year ended December 31, 2021, and provided a business update.

  February 24, 2022

   · 

  22 min read